Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
A Study of MKC-442 in HIV-Positive Patients Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about A Study of MKC-442 in HIV-Positive Patients conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A Study of MKC-442 in HIV-Positive Patients Clinical research trials and A Study of MKC-442 in HIV-Positive Patients health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like A Study of MKC-442 in HIV-Positive Patients. A Study of MKC-442 in HIV-Positive Patients Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a A Study of MKC-442 in HIV-Positive Patients clinical trial. Subjects frequently get the best healthcare possible for their A Study of MKC-442 in HIV-Positive Patients condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.

Home > "A" Clinical Trials Conditions > A Study of MKC-442 in HIV-Positive Patients

A Study of MKC-442 in HIV-Positive Patients



A Study of MKC-442 in HIV-Positive Patients

For Condition: HIV Infections
Status: Completed
Sponsor(s): Triangle Pharmaceuticals ,
Synopsis: The purpose of this study is to see if it is safe and effective to give MKC-442 plus at least two other anti-HIV drugs to patients who have never been treated with nonnucleoside reverse transcriptase inhibitors but who have been treated with nucleoside reverse transcriptase inhibitors and protease inhibitors. This study also determines how long a drug combination including MKC-442 is effective.
Details:
Eligibility:
Study Type:  Interventional, Treatment, Open Label, Safety Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Concurrent Medication: Allowed: Based on medical history, medical condition, prior use of antiretroviral drugs, and genotypic analysis of the predominant strain of HIV-1 isolated from plasma, administration of at least 2 available antiviral agents by prescription may be given with MKC-422. Patients must have: HIV infection with HIV-1 RNA greater than or equal to 2,000 by Roche Amplicor method, within 30 days of entry. Prior Medication: Allowed: - Prior nucleoside reverse transcriptase and protease inhibitors. - Cytotoxic chemotherapy more than 30 days prior to entry. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Malabsorption or severe chronic diarrhea within 30 days prior to entry, or inability to consume adequate oral intake because of chronic nausea, emesis, or abdominal or esophageal discomfort. - Inadequately controlled seizure disorder. - Acute and clinically significant medical event within 30 days of screening. - Any clinical or laboratory abnormality greater than Grade 3 toxicity, with the exception of the listed laboratory values. Prior Medication: Excluded: - Non-nucleoside reverse transcriptase inhibitor therapy. - Any unapproved experimental antiretroviral therapy. Prior Treatment: Excluded: - Radiation therapy within 30 days of entry, except to a local lesion. - Transfusion of blood or blood products within 21 days of screening. Risk Behavior: Excluded: Active substance abuse that may interfere with compliance or protocol evaluations.
Total Enrollment: 

Location and Contact Information:


Additional Information:
Study ID Numbers:  292B;  MKC-304
Study Start Date: 
Record last reviewed: April 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002413

Other Hiv Infections Studies:
1. Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

2. Use of Muscle Spectroscopy to Evaluate Mitochondrial Dysfunction in HIV-Infected Patients

3. The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients with Hepatitis C Plus Advanced HIV Infections

4. A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

5. Safety and Effectiveness of Treating HIV-Positive Patients with an HIV Vaccine (Remune)

Related Studies:

Other HIV Infections Clinical Trials
Other Clinical Trials
Other Clinical Trials

A Study of MKC-442 in HIV-Positive Patients
Modify your Search

  Other HIV Infections Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103